Abbott Laboratories (ABT) vs Stryker Corporation (SYK)
ABT leads on 9 of 16 compared metrics.
A side-by-side comparison of Abbott Laboratories and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 19, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABT vs SYK
growth of $100 · last 30yABT +812.1%SYK +4866.9%SYK compounded faster
Log scale — wide-divergence pair
ABT SYK
ABT vs SYK: by the numbers
- •ABT is the larger company ($153.94B vs $119.03B market cap).
- •ABT trades at the lower earnings multiple (24.62 vs 34.85 P/E).
- •ABT converts more revenue to profit (13.91% vs 13.21% net margin).
- •SYK grew revenue faster over the past five years (11.42% vs 3.87% CAGR).
- •ABT pays the higher dividend yield (2.76% vs 1.14%).
Which is better, ABT or SYK?
Metric tally: ABT 9 · SYK 7It depends on what you're optimizing for:
ValueABT(lower P/E)
GrowthSYK(faster 5Y revenue CAGR)
IncomeABT(higher dividend yield)
Metrics side by side
Valuation
| Metric | ABT | SYK |
|---|---|---|
| P/E ratio | 24.62● | 34.85 |
| Forward P/E | 14.60● | 18.00 |
| P/S ratio | 3.42● | 4.61 |
| P/B ratio | 2.97● | 5.07 |
| PEG ratio | 2.99● | 5.16 |
| EV / EBITDA | 16.21● | 20.89 |
| FCF yield | 4.78%● | 3.93% |
Profitability
| Metric | ABT | SYK |
|---|---|---|
| Gross margin | 56.38% | 63.67%● |
| Operating margin | 18.17% | 21.34%● |
| Net margin | 13.91%● | 13.21% |
| ROE | 12.06% | 14.52%● |
| ROIC | 8.43% | 8.53% |
Dividends
| Metric | ABT | SYK |
|---|---|---|
| Dividend yield | 2.76%● | 1.14% |
| Payout ratio | 65.24% | 40.52% |
Growth (annualized)
| Metric | ABT | SYK |
|---|---|---|
| Revenue CAGR (5Y) | 3.87% | 11.42%● |
| EPS CAGR (5Y) | 8.22% | 14.79%● |
| FCF CAGR (5Y) | -0.61% | 11.01%● |
| Total return CAGR (5Y) | -2.52% | 5.09%● |
Frequently asked
- Which is better, ABT or SYK?
- It depends on your goal. value: ABT (lower P/E); growth: SYK (faster 5Y revenue CAGR); income: ABT (higher dividend yield). Across all compared metrics, ABT leads 9 to 7.
- Is ABT or SYK cheaper?
- On trailing earnings, ABT is cheaper: ABT trades at a 24.62 P/E and SYK at 34.85.
- Which has grown faster, ABT or SYK?
- Over the past five years, SYK grew revenue faster — ABT at a 3.87% CAGR versus SYK at 11.42%.
- Does ABT or SYK pay a bigger dividend?
- ABT yields 2.76% and SYK yields 1.14% based on trailing dividends and the latest price.
- Is ABT or SYK more profitable?
- ABT runs the higher net margin — ABT at 13.91% versus SYK at 13.21%.
- Which has been the better investment, ABT or SYK?
- Over the past 10-year, SYK delivered the higher annualized total return — ABT at 11.04% versus SYK at 11.73%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioStryker P/E ratioAbbott Laboratories dividend yieldStryker dividend yieldAbbott Laboratories ROEStryker ROEAbbott Laboratories operating marginStryker operating marginAbbott Laboratories revenue growthStryker revenue growthAbbott Laboratories free cash flowStryker free cash flow
Abbott Laboratories & Stryker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 19, 2026.